Forsyth Douglasinsider trades

In SEC Form 4 filings, Forsyth Douglas is listed as Director of Inhibrx Biosciences, Inc. (INBX). In the last 90 days, Forsyth Douglas bought $286.6K of Inhibrx Biosciences, Inc. (INBX) on the open market and sold none. The purchase was $286.6K of Inhibrx Biosciences, Inc. (INBX) on Sep 8.

Companies and roles

Company	Role	Transactions	Last filed
INBXInhibrx Biosciences, Inc.	Director	2	Sep 18

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

Dashed line = amended filing (Form 4/A)

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
INBXInhibrx Biosciences, Inc.	Jun 3	Sep 184/A	A · derivative	10,000	$95.22	$952,200	10,000	No	Form 4/A
INBXInhibrx Biosciences, Inc.	Sep 8	Sep 8	P	2,500	$114.65	Purchase +$286,617	227,064	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.